ArticlePharmaceutics2026

Analytical Physicochemical and Functional Studies to Compare AryoTrust, a Follow-On Biologics, with the Originator Trastuzumab (Herceptin).

Khalid Kadhem Al-Kinani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.